J. Clin. Med., 2022 · DOI: 10.3390/jcm11123344 · Published: June 10, 2022
This study examines the use of a cognitive assessment tool (NUCOG) for detecting mild cognitive impairment (MCI) in adults with spinal cord injury (SCI). It highlights the lack of specialized neurocognitive screens designed specifically for SCI and the inconsistent criteria used to define MCI in this population. The research assesses the NUCOG's ability to differentiate between individuals with and without MCI following SCI, considering factors like time since injury. It also explores the structural validity of the NUCOG's cognitive domains. The findings suggest that while the NUCOG can detect cognitive differences in SCI patients, its suitability for MCI assessment has limitations, indicating the need for a tailored neurocognitive screen for this population.
The findings support the development of a neurocognitive screen tailored for adults with SCI to address the unique cognitive challenges and improve the accuracy of MCI detection.
The study emphasizes the need for universally agreed-upon criteria for detecting probable MCI in SCI to allow for reliable assessment and appropriate referral for comprehensive neurocognitive assessment.
The research suggests that a specialized test should target cognitive domains affected by SCI, such as executive functioning and attention/processing speed, to enable more effective and personalized cognitive rehabilitation strategies.